← FDA MEDWATCH
FDA (US) · FDA PRESS RELEASEJuly 17, 2026
FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol
What this record is not
Item details are published by the U.S. FDA on fda.gov; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA. The authoritative notice is on fda.gov.
Item type
FDA Press Release
Published
July 17, 2026
Source
U.S. FDA (MedWatch / press releases)
READ THE FULL FDA NOTICE
The complete FDA notice — the affected products, the action required, and any recall detail — is published on fda.gov. SPEQ surfaces and indexes it for reference; the authoritative notice lives on fda.gov.
View on fda.gov →